Future Health Index, Commissioned by Philips, Identifies Key Recommendations for Better Health Information Exchange to Drive Value in Healthcare

Royal Philips

Future Health Index, Commissioned by Philips, Identifies Key Recommendations for Better Health Information Exchange to Drive Value in Healthcare

PR75300

AMSTERDAM, Sept. 20, 2018 /PRNewswire=KYODO JBN/ --

Royal Philips [http://www.philips.com/] (NYSE: PHG) (AEX: PHIA), a global

leader in health technology, today released a new Future Health Index (FHI)

report "Moving data to the heart of health systems: Increasing vital technology

adoption to make value-based healthcare a reality"

[https://www.futurehealthindex.com/report/2018/part/2/]. The research focused

on two technology enablers that have the potential to advance integration, and

enable data to be used more effectively. Digital identity tools, such as

Electronic Health Records (EHRs), based on standardized data and protocols that

can be accessed, used and updated by care providers across the health

continuum, can make the collection and exchange of healthcare data much easier.

Data analytics and AI can mine that data for connections and insights that will

benefit both healthcare professionals and patients. This ranges from the

identification of health trends at the level of an entire population, to more

precise diagnosis, treatment and after care for individual patients.

The latest FHI report identifies the following key recommendations for the way

in which health data is collected, shared and used, in order for countries to

meet their goals of driving better value in healthcare:

- Strike the right balance in data protection and (de)regulation

- Foster adoption through education - only 47% of healthcare professionals

surveyed and 24% of the general population felt knowledgeable about connected

care technologies

- Secure buy-in through co-creation of solutions together with healthcare

professionals and the general population

- Harmonize data collection and use practices - countries with universal EHRs

have a higher Value Measure [

https://www.philips.com/a-w/about/news/archive/standard/news/press/2018/20180614-philips-commissioned-future-health-index-outlines-journey-to-value-based-healthcare.html

] than countries without universal EHRs (47.29 on average vs 39.67), as well as

higher average levels of trust (67.79 vs. 62.99)

"The Future Health Index's latest report

[https://www.futurehealthindex.com/value-measure/] shows that the smooth

exchange of health information is central to delivering better value in

healthcare," said Jan Kimpen, Chief Medical Officer for Philips. "By connecting

people, data and systems we can create a network that allows information to

flow seamlessly across care providers, locations and systems. It is through

data that the outcomes that define value are tracked, measured and improved.

Yet, health systems around the world are still struggling to collect, organize,

analyze and use health data in a meaningful way. The recommendations made in

the FHI are designed to address these very challenges and provide actionable

next steps that healthcare leaders can take to optimize the value provided by

the digital tools they are investing in."

FHI is a research-based platform designed to help determine the readiness of

countries to address global health challenges and build sustainable,

fit-for-purpose national health systems. Using the real-life learning of

experts in the field, and insights uncovered in research, the FHI provides

actionable recommendations for the healthcare industry; particularly around the

adoption and implementation of crucial digital tools that can deliver more

affordable, integrated and sustainable care. A key finding of the FHI is that

integrating connected care technology into health systems can accelerate

countries along the path to value-based healthcare.

To download the Future Health Index 2018 report in its entirety, please visit:

https://www.futurehealthindex.com/report/2018/part-2-moving-data-to-the-heart-of-health-systems.

For additional Future Health Index related content, please visit

https://www.futurehealthindex.com/.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company

focused on improving people's health and enabling better outcomes across the

health continuum from healthy living and prevention, to diagnosis, treatment

and home care. Philips leverages advanced technology and deep clinical and

consumer insights to deliver integrated solutions. Headquartered in the

Netherlands, the company is a leader in diagnostic imaging, image-guided

therapy, patient monitoring and health informatics, as well as in consumer

health and home care. Philips generated 2017 sales of EUR 17.8 billion and

employs approximately 75,000 employees with sales and services in more than 100

countries. News about Philips can be found at http://www.philips.com/newscenter.

For further information, please contact:

Elena Calamo Specchia

Philips Group Press Office

Tel.: +31-6-25004735

E-mail: Elena.Calamo.Specchia@philips.com

SOURCE: Royal Philips

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中